3345 COMBI-v: health-related quality of life (HRQoL) impact of the combination of dabrafenib and trametinib (D+T) vs vemurafenib (V) in patients with BRAF V600 metastatic melanoma (MM)
Grob, J.J., Amonkar, M., Karaszewska, B., Schachter, J., Dummer, R., Mackiewicz, A., Stroiakovski, D., Drucis, K., Grange, F., Chiarion-Sileni, V., Rutkowski, P., Lichinitser, M., Levchenko, E., WolteVolume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31863-9
Date:
September, 2015
File:
PDF, 67 KB
english, 2015
File converter
More search results
More benefits 
